HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Expansion of ‘Right to Try’ legislation raises ethical, safety concerns
• ASH announces award recipients
• CMS releases 2015 Quality Measures Report
• Pancreatic cancer: Great expectations or false promises Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
• FDA grants marketing authorization for direct-to-consumer genetic test for Bloom syndrome
• FDA grants orphan drug designation to AG-348 for pyruvate kinase deficiency
• FDA grants orphan drug designation to sevuparin for sickle cell disease
• FDA grants priority review for expanded use of Kyprolis in relapsed multiple myeloma
• FDA issues final guidance on medical device data systems
• State of the science: High-priority transplant trials for nonmalignant disease Hemant Murthy, MD; William Wood, MD
• Adjuvant radiotherapy may benefit patients with lymph node-positive vulvar cancer
• 80% adherence to colorectal cancer screening could prevent 200,000 deaths by 2030
• Active surveillance may be appropriate for favorable intermediate-risk prostate cancer
• Addition of ibrutinib to chemoimmunotherapy shows promise for CLL
• Blood transfusions during CABG increased risk for pneumonia
• Bortezomib-based therapy improves outcomes, increases toxicity in mantle cell lymphoma
• Breast cancer screening program highlights health care disparities
• Cancer fear limits colorectal cancer screening uptake
• Cancer prevalence low in women who undergo myomectomy with electric power morcellation
• Chest CT imaging may safely be omitted from neuroblastoma surveillance for pediatric patients
• Combination of trastuzumab, XELOX shows promise for advanced gastric cancer
• Defibrotide represents ‘major advance’ for severe veno-occlusive disease after HSCT
• Despite clinical success, laparoscopic colectomy underused in colon cancer treatment
• Despite fewer smokers, poor screening criteria may raise lung cancer mortality
• DNA from breast cancer tumors could lead to genotype misclassification
• Early alopecia linked to favorable outcomes in epithelial ovarian cancer
• Extra-virgin olive oil ingredient rapidly induces cancer cell death
• Fondaparinux found to be effective in prevention of thrombotic events in patients with HIT
• Four-factor prothrombin complex concentrate shows promise for urgent vitamin K antagonist reversal
• HSCT outcomes similar in pediatric ALL regardless of donor type
• Ibrutinib discontinuation linked to poor prognosis in CLL
• Informed choice for breast cancer screening may result in fewer mammograms
• Lenalidomide combination fails to improve survival in castration-resistant prostate cancer
• Low testosterone predicts improved outcomes with continuous ADT in prostate cancer
• Low-dose iron supplementation improves hemoglobin recovery after blood donation
• Model predicts bloodstream infection risk in febrile pediatric cancer patients
• Most benign thyroid nodules remain benign during follow-up
• MRI improved mammography screening sensitivity for older BRCA mutation carriers
• MRI shows greater screening sensitivity for familial breast cancer
• Oncologists examine rising costs of cancer drugs
• Parents interested in whole genome sequencing for themselves, children
• Prior MGUS diagnosis increases multiple myeloma survival
• Prostate cancer diagnosis in first-degree relative increases woman's risk for breast cancer
• Reconstruction for pelvic tumors achieves satisfactory survival, increases complication rates
• Reporting of noninferiority trial results needs improvement
• Safety policies, data protection needed for BYOD in health care
• Scent-trained canine detects thyroid cancer in urine samples, could aid in diagnoses
• Smoking, alcohol may increase gastrostomy duration in head and neck cancers
• Smoking increases mortality risk in patients with colorectal cancer
• Testosterone therapy did not increase prostate cancer risk in hypogonadal men
• The Challenge of Submassive Pulmonary Embolism
• Time-dependent treatment may lead to better CML outcomes
• Two-thirds of patients with invasive cancer likely to survive 5 years
• Variation in risk for late mortality among pediatric cancer survivors can persist up to 20 years post-diagnosis
• Waldenström’s macroglobulinemia increases risk for secondary malignancies
• Wide excision, Mohs micrographic surgery effectively treated primary lentigo maligna
• AACR announces president-elect
• AACR presents achievement award
• ASCO to honor several researchers
• Lymphoma expert joins City of Hope
• MD Anderson names division head
• St. Jude appoints chair of radiation
• Weill Cornell names chair of radiation
• Algorithm to test microRNA on fine needle aspiration could improve molecular cytology diagnostic yield
• Extent of spinal metastasis should drive patient-centered management of MESCC
• HIV did not affect HCC recurrence or survival after LT
• MM-398 improved outcomes in metastatic pancreatic cancer
• Thyroid cancer risk greater in survivors of breast cancer